LAB
Standard Biotools Inc
0.7698$
+5.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
Standard Biotools Inc (LAB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -74 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -22 | -22 | -29 | -20 | -12 | -18 | -17 | -1.6 | -23 | -35 | -39 | -24 | -25 | -35 | -15 | -44 | -89 | -43 | -143 | -74 | |
| 1.5 | 2.1 | 2.0 | 1.9 | 1.5 | 1.1 | 1.5 | 2.6 | 4.1 | 16 | 18 | 19 | 17 | 18 | 16 | 16 | 15 | 15 | 17 | 1.7 | |
| 0.1 | 0.7 | 2.0 | 2.1 | 1.6 | 2.8 | 4.1 | 6.4 | 21 | 17 | 14 | 9.1 | 11 | 11 | 14 | 16 | 15 | 13 | 32 | 30 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 12 | 25 | 17 | 18 | 31 | – | – | – | |
| -1.2 | 0.5 | -2.5 | -2.7 | 1.9 | -1.0 | -4.1 | 6.7 | -7.8 | -8.2 | 4.8 | 9.2 | -2.5 | -17 | 2.4 | -18 | -12 | 1.8 | -12 | -45 | |
| 2.9 | 1.0 | 0.9 | 0.8 | 1.5 | 1.7 | 2.4 | 4.7 | 7.4 | 11 | 5.1 | 1.6 | 0.4 | 2.5 | 13 | 13 | 3.8 | 2.8 | 8.4 | 8.3 | |
| -2.9 | -6.7 | 6.0 | -0.7 | -1.3 | -45 | 14 | -28 | -178 | 26 | 45 | 18 | 4.7 | -39 | 40 | -12 | -88 | 20 | 363 | 25 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 1.5 | – | 0.3 | – | – | – | – | |
| -0.1 | – | – | – | – | – | – | – | – | -0.2 | -0.1 | 29 | 61 | -0.6 | -0.5 | -1.8 | -0.8 | -5.4 | -41 | 1.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 3.2 | 3.2 | 16 | 16 | 5.6 | -2.1 | -63 | 0.0 | |
| 31 | 38 | 6.3 | 17 | 3.8 | 70 | 49 | 5.8 | 200 | 5.3 | 0.1 | 29 | 58 | 2.8 | 21 | 16 | 231 | -6.8 | -103 | 0.6 | |
| 5.9 | 9.1 | -16 | -3.2 | -8.9 | 7.8 | 45 | -23 | -1.5 | -4.6 | 5.9 | 23 | 37 | -72 | 46 | -40 | 53 | -30 | 116 | -48 | |
| -25 | -23 | -30 | -20 | -13 | -19 | -20 | -6.3 | -30 | -45 | -44 | -26 | -26 | -38 | -28 | -57 | -93 | -46 | -152 | -83 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.